Therapeutic Areas
At Novatrials, we can state with confidence that we offer our clients efficiency, savings in resources and superior data quality, ensuring that your therapy, drug or medical device in any of these therapeutic areas stands up to local and global requirements.
Before we embark on the trial itself, we shall determine its viability to avoid spiraling costs and expanding timelines. Using our extensive experience, we shall help you identify risks to your study and put in place strategies to mitigate them.
Our team has vast clinical experience in conducting research of pharmaceutical products for the following medical indications:
Oncology
Breast Cancer
Gastric Cancer
Pancreatic Cancer
Renal Cell Carcinoma
Colorectal Cancer
NSCLC
Melanoma
MDS/AML
Solid Tumors
Respiratory
Cystic Fibrosis
Asthma
COPD
Hematology
Thrombocytopenia
Neurology
DMD - Duchenne muscular dystrophy
Endocrinology
GHD – Growth Hormone Deficiency
Infectious diseases
HIV
Metabolic
NASHObesity
Type 2 Diabetes Mellitus
Orthopedic
Osteoarthritis
Arthroscopic Surgery
Radiology/Radiation:
SIRT – Selective Internal Radiation Therapy
CTO – Chronic Total Occlusions
Ophthalmology
Corneal Edema - Lens
Corneal Edema – Implant
Urology
BPH-Benign Prostate Hypertrophy
Gynecology
IUB-Intra Uterine Ball
Genetic and Pharmacogenetics studies
Despite the regulatory challenges that have traditionally held up the approval in Israel of studies in which genetic information has been collected, we have successfully obtained long-term approvals for sub-research in all indications, with particularly attractive schedules.
Advanced Therapy
CAR T-Cells
Mesenchymal stem cells
Anti-angiogenic agents based on an adenovirus vector